Maxnerva Technology Services Limited (01037) Reports February 2026 Equity Movements

Bulletin Express
03/03

For the month ended 28 February 2026, the authorized share capital remained at 1,000.00 million shares with a par value of HKD 0.10 each, totaling HKD 100.00 million. The total number of issued ordinary shares stood at 706.17 million, and no changes were recorded in the issued share capital or treasury shares during the month.

The public float continued to meet the 25% regulatory requirement. Share options granted on 31 August 2017, 12 November 2018, and 9 April 2022 showed no changes during the period, with no additional shares issued. No warrants, convertibles, or other agreements caused any alterations in the share capital.

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10